The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
He brings extensive cross-functional expertise built through leadership roles
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
The innovation leverages Mitsui Chemicals’ oxygen-permeable InnoCell cell culture plate to efficiently collect bile while reducing stress on liver cells
Eylea 2mg (intravitreal aflibercept injection) is an anti-VEGF therapy that blocks a protein responsible for abnormal blood vessel growth and leakage in the retina
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
Subscribe To Our Newsletter & Stay Updated